Abstract: Mycosis fungoides is a cutaneous T-cell lymphoma with various clinical and pathological presentations. Early lesions are nonspecific, which hinders early diagnosis. The folliculotropic subtype is manifested as acneiform lesions, follicular papules or erythematous plaques mainly on the face, neck and upper trunk. Histopathology shows dense lymphocytic infiltrate surrounding and infiltrating the hair follicles. A case of difficult histopathological diagnosis with florid and unusual skin lesions mainly on the face is reported.
INTRODUCTION
Mycosis fungoides is considered the most common type of cutaneous T-cell lymphoma, despite being rare. 1 Early diagnosis of the condition is challenging for dermatologists because the initial clinical and histopathological features can be unspecific. It has a prolonged course, sometimes mimicking benign dermatoses. 2 Folliculotropic mycosis fungoides is the most common variant. It can present with plaques, acneiform lesions or as a tumor, being alopecia and eyebrow involvement typical. On histology, there is a dense lymphocytic infiltrate around hair follicles, sometimes with destruction of the follicle. In the early phases, there is a mild perivascular inflammatory infiltrate in the upper dermis with no obvious lymphocyte atypia. 3 The prognosis of this type of mycosis fungoides is poorer, with the survival ranging from 70 to 80% in five years. 4 The authors describe a case with unusual and florid clinical presentation, of difficult histopathological and immunohistochemical diagnosis.
CASE REPORT
A 63-year-old dark-skinned male patient, hypertensive, such as CD2, CD5 and/or CD7. 8 Large CD30+ blast cells can be seen interspersed within the infiltrate. 4 The histologic pattern of the reported patient demonstrated granulomatous reaction associated to the folliculotropic pattern with CD30+ cells, which are uncommon
findings. An important differential diagnosis is the extranodal NK/ T-cell lymphoma nasal-type, that predominantly affects the nasal cavity and nasopharynx but whose cells are CD4 and CD5 negative.
